Home Cervical Cancer Screening Uptake in a Large Community-Based General Screening Population - Report - MDSpire

Home Cervical Cancer Screening Uptake in a Large Community-Based General Screening Population

  • By

  • Elizabeth J. Suh-Burgmann

  • Yun-Yi Hung

  • Tracy Seo

  • Kari Carlson

  • Julie A. Schmittdiel

  • June 26, 2026

  • 0 min

Share

Utilization of At-Home Cervical Cancer Screening in a Broad Community-Based General Population

Overview

This study assessed the uptake and yield of at-home cervical cancer screening in a diverse community-based population. A total of 13,714 eligible patients were offered home screening, with an opt-in rate of 18.6% and a sample return rate of 54.0% within 60 days. The median age of participants was 43 years.

Background

Self-collected vaginal sampling for HPV testing is a guideline-endorsed option that may enhance cervical cancer screening participation. Understanding the uptake and effectiveness of this method in community settings is crucial for improving screening rates, especially among underserved populations. Previous studies have shown varying levels of participation in self-collection methods.

Data Highlights

CharacteristicValue
Total patients offered home screening13,714
Opt-in rate18.6%
Sample return rate54.0%
Median age of participants43 years
Demographics26.1% Asian or Pacific Islander, 6.2% Black, 20.9% Hispanic, 39.1% White, 7.8% mixed race or other

Key Findings

  • Opt-in rates were higher among older patients and those with a higher comorbidity index.
  • White patients comprised 49.4% of those opting for home screening.
  • Patients with unknown screening history were less likely to opt in for home screening.
  • Sample return rates were lower among patients with higher BMI and comorbidity burden.
  • Travel distance did not significantly affect sample return rates.

Clinical Implications

The findings indicate that demographic factors such as age and race influence participation in at-home cervical cancer screening.

Conclusion

The study provides insights into the engagement of a broader population in at-home cervical cancer screening, highlighting challenges in achieving higher sample return rates among certain demographic groups.

Related Resources & Content

  1. The ASCO Post, 2025 -- Mailed Self-Collection HPV Tests Improve Cervical Cancer Screening Rates, Study Finds
  2. JAMA Internal Medicine, 2022 -- Mailed Outreach for Colorectal Cancer Screening in Community Health Centers: The CARES Pragmatic Cluster
  3. The ASCO Post, 2022 -- Study Finds Use of Remote Interventions Improved Adherence to Cancer Screenings Among Women Living in Rural Areas KEY POINTS
  4. conexiant -- FDA Clears At-Home HPV Screening Tool
  5. FDA -- cobas HPV Test for 4800 System – P100020/S055
  6. Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee - PMC
  7. NCI Launches Network to Study Self-Collection for HPV Testing to Prevent Cervical Cancer | Division of Cancer Prevention
  8. cobas HPV Test for 4800 System – P100020/S055 | FDA
  9. Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee - PMC
  10. NCI Launches Network to Study Self-Collection for HPV Testing to Prevent Cervical Cancer | Division of Cancer Prevention

Original Source(s)

Related Content